aTyr Pharma plans trial for Covid-19 respiratory complications
The drug candidate is being developed to treat interstitial lung diseases. Credit: Robina Weermeijer on Unsplash.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more